Regional anticoagulation and antiaggregation for CVVH in critically ill patients: A prospective, randomized, controlled pilot study

Acta Anaesthesiologica Scandinavica

Volumn 54, Issue 1, 2010, Pages 92-97

  Fabbri, L P ^a   Nucera, M ^a   Al Malyan, M ^a   Becchi, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROSTACYCLIN; PROTAMINE SULFATE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMIC MONITORING; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

AGED; ANTICOAGULANTS; CRITICAL ILLNESS; EPOPROSTENOL; FEMALE; HEMOFILTRATION; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MICROPORE FILTERS; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROSPECTIVE STUDIES; PROTAMINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 72249099861     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.02031.x     Document Type: Article

References (19)

1. Langenecker SA, Felfernig M, Werba A, Mueller CM, Chiari A, Zimpfer M. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. Crit Care Med 1994 22 : 1774 1781.
2. Saner F, Hertl M, Broelsch CE. Anticoagulation with hirudin for continuous veno-venous hemodialysis in liver transplantation. Acta Anaesthesiol Scand 2001 45 : 914 918.
3. Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 1997 30 : S20 7.
4. Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB. Regional heparinization for hemodialysis. Technical and clinical experiences. N Engl J Med 1963 268 : 451 456.
5. Kaplan AA, Petrillo R. Regional heparinization for continuous arteriovenous hemofiltration (CAVH). Trans Am Soc Artif Intern Organs 1987 33 : 312 315.
6. Ponikvar R, Kandus A, Buturovic J, Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib Nephrol 1991 93 : 218 220.
7. Tan HK, Baldwin I, Bellomo R. Continous veno-venous hemofiltration without anticoagulation in high risk patients. Int care Med 2000 26 : 1652 1657.
8. World Medical Association. Ethical principles for medical research involving human subjects. Eur J Emerg Med 2001 8 : 221 224.
9. Sigdell JE. Operating characteristics of hollow-fibers dializers. In : Nissenson AR, Fine RN, Gentile, eds. Clinical dialysis. East Norwalk, CT : Appleton & Lange, 1990 : 97 117.
10. Bellomo R, Teede H, Boyce N. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Int Care Med 1993 19 : 329 332.
11. Biancofiore G, Esposito M, Bindi L, Stefanini A, Bisà M, Boldrini A, Consani G, Filippini F, Mosca F. Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients. Minerva Anestesiol 2003 69 : 527 538.
12. Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J Nephrol 2003 16 : 566 571.
13. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Int Care Med 2003 29 : 575 578.
14. Van der Voort PHJ, Gerritsen RT, Kuiper MA, Egbers PHM, Kingma WP, Boerma EC. Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif 2005 23 : 175 180.
15. Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 2007 30 : 301 307.
16. Baldwin I, Tan HK, Bridge N, Bellomo R. Possible strategies to prolong circuit life during hemofiltration: three controlled studies. Renal Failure 2002 6 : 839 848.
17. O'Grady J, Warrington S, Moti MJ, Bunting S, Flower R, Fowle AS, Higgs EA, Moncada S. Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins 1980 19 : 319 332.
18. Hampers CL, Blaufox MD, Merrill JP. Anticoagulation rebound after hemodialysis. N Engl J Med 1966 275 : 776 778.
19. Carr JA, Silverman N. the heparin-protamine interaction. J Cardiovasc Surg 1999 50 : 659 666.